Sort
11,323 grants matching “glioblastoma”
Project 1: Active immunotherapy combined with checkpoint modulation for glioblastoma
$352,032Robert M Prins · University Of California Los Angeles · P50 · FY2017 · CA
Tumor cell and microenvironment changes causing antiangiogenic therapy resistance
$352,024Manish Aghi · University Of California, San Francisco · R01 · FY2021 · NS
AUGMENTING IN VIVO EFFICACY OF A NOVEL LANOSTEROL SYNTHASE INHIBITOR IN GLIOBLASTOMA
$352,000Sloan-Kettering Institute For Cancer Research · · FY2025 · Defense Health Agency
Proj. 3: Immunosuppressive circuits in T cells and other immune cells in GBM patients enrolled in clinical trials
$351,997Kai W Wucherpfennig · Brigham And Women'S Hospital · P01 · FY2022 · CA
Proj. 3: Immunosuppressive circuits in T cells and other immune cells in GBM patients enrolled in clinical trials
$351,997Kai W Wucherpfennig · Brigham And Women'S Hospital · P01 · FY2023 · CA
Tumor cell and microenvironment changes causing antiangiogenic therapy resistance
$351,943Manish Aghi · University Of California, San Francisco · R01 · FY2020 · NS
Mechanism-based drug repurposing and novel treatments for glioblastoma
$351,894Mark D Noble · University Of Rochester · R01 · FY2017 · CA
Project 4: Novel epigenetic treatment of IDH mutant gliomas
$351,815Harley I Kornblum · University Of California Los Angeles · P50 · FY2020 · CA
Novel multipronged Immunovirotherapy Approach for GBM Treatment
$351,804Evanthia Galanis · Mayo Clinic Rochester · R01 · FY2022 · CA
Computational Approaches for RNA StructureFunction Determination
$351,760Bruce Shapiro · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Core 2: Analytical Core
$351,745Nathalie Yr Agar · Massachusetts Institute Of Technology · U54 · FY2023 · CA
Developing nonmuscle myosin II inhibitors for the treatment of glioblastoma
$351,725Courtney A Miller · Scripps Florida · R61 · FY2021 · NS
Validation of microRNA Targets in Glioma
$351,692Anna M. Krichevsky · Brigham And Women'S Hospital · R01 · FY2012 · CA
Functional Inhibition of Deubiquitylase HAUSP to Disrupt Glioblastoma Stem Cells
$351,691Shideng Bao · Cleveland Clinic Lerner Com-Cwru · R01 · FY2019 · CA
Computational and Experimental Modeling of Alternative Polyadenylation
$351,691Wei Li · Baylor College Of Medicine · R01 · FY2019 · CA
The Role of White Matter Progenitors in Glioma Formation and Progression
$351,549Peter D Canoll · Columbia University Health Sciences · R01 · FY2010 · NS
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression
$351,450Ji Ming Wang · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Mechanisms of adhesion and invasion in hyaluronic acid matrices
$351,388Sanjay Kumar · University Of California Berkeley · R01 · FY2023 · CA
Mechanisms of adhesion and invasion in hyaluronic acid matrices
$351,387Sanjay Kumar · University Of California Berkeley · R01 · FY2022 · CA
Therapeutic modulation of angiogenesis in human gliomas
$351,135Erwin G Van Meir · Emory University · R01 · FY2007 · CA
Therapeutic modulation of angiogenesis in human gliomas
$351,135Erwin G Van Meir · Emory University · R01 · FY2009 · CA
Polyamine Catabolism and Therapeutic Resistance in Glioblastoma Multiforme
$351,131Scott Michael Welford · University Of Miami School Of Medicine · R01 · FY2017 · CA
Project 3: A New Therapeutic Target for TERT Promoter Mutant Glioma
$351,130Joseph F Costello · University Of California, San Francisco · P50 · FY2022 · CA
Project 3: A New Therapeutic Target for TERT Promoter Mutant Glioma
$351,127Joseph F Costello · University Of California, San Francisco · P50 · FY2021 · CA
Drivers of metabolic plasticity promote radiation resistance in glioblastoma multiforme
$351,000Erina Vlashi · University Of California Los Angeles · R01 · FY2023 · CA